Carino Gurjao’s research focuses on the omics analysis of cancer. He investigates DNA patterns in the tumor genome to better understand what factors shape these patterns and how they can in return inform clinical decisions. Carino previously wrote his thesis on the use of passenger mutations to treat and prevent cancer.

From Lyon to Paris, via Boston, Carino Gurjao studied at the Institut Curie, MIT and Harvard (Dana-Farber Cancer Institute and Broad Institute). At the University of Paris, his doctoral thesis demonstrated, for the first time in humans, the mutagenic effect of red meat consumption on colorectal cancer. As a postdoctoral fellow at Columbia University in New York, he conducted DNA analysis of the largest cohort of African-American patients with colorectal cancer to date. His publications already include more than twelve articles that have appeared in recognized journals. In 2022, he was named by Forbes as one of the 30 most influential people under the age of 30 in the field of health.